Europe — Total revenues
Gilead Sciences Europe — Total revenues decreased by 7.4% to $1.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.5%, from $1.08B to $1.14B. Over 3 years (FY 2022 to FY 2025), Europe — Total revenues shows an upward trend with a 4.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful product adoption, favorable pricing, or expanded market access in Europe, while a decrease may signal increased competition, patent expirations, or regulatory pricing pressures.
Detailed definition
This metric represents the total gross income generated from the sale of pharmaceutical products and services within the...
Peer comparison
Comparable to regional revenue reporting by other multinational pharmaceutical companies, which typically track performance by major geographic segments to isolate regional economic and regulatory impacts.
gild_segment_europe_total_revenuesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.12B | $1.12B | $1.12B | $1.12B | $1.08B | $1.08B | $1.08B | $1.08B | $1.16B | $1.13B | $1.17B | $1.18B | $1.08B | $1.19B | $1.56B | $1.24B | $1.14B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -3.6% | +0.0% | +0.0% | +0.0% | +7.6% | -2.2% | +3.0% | +0.7% | -7.7% | +9.7% | +30.8% | -20.5% | -7.4% |
| YoY Change | — | — | — | — | -3.6% | -3.6% | -3.6% | -3.6% | +7.6% | +5.2% | +8.3% | +9.0% | -6.5% | +4.9% | +33.2% | +5.2% | +5.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's europe — total revenues?
- Gilead Sciences (GILD) reported europe — total revenues of $1.14B in Q1 2026.
- How has Gilead Sciences's europe — total revenues changed year-over-year?
- Gilead Sciences's europe — total revenues increased by 5.5% year-over-year, from $1.08B to $1.14B.
- What is the long-term trend for Gilead Sciences's europe — total revenues?
- Over 3 years (2022 to 2025), Gilead Sciences's europe — total revenues has grown at a 4.3% compound annual growth rate (CAGR), from $4.47B to $5.06B.
- What does europe — total revenues mean?
- The total amount of money earned from sales in the European market.